Logo image of CHEK

CHECK CAP LTD (CHEK) Stock Fundamental Analysis

NASDAQ:CHEK - IL0011336851 - Common Stock

0.7339 USD
+0.09 (+14.05%)
Last: 8/29/2025, 8:12:29 PM
0.681 USD
-0.05 (-7.21%)
After Hours: 8/29/2025, 8:12:29 PM
Fundamental Rating

2

Overall CHEK gets a fundamental rating of 2 out of 10. We evaluated CHEK against 185 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for CHEK as it has an excellent financial health rating, but there are worries on the profitability. CHEK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CHEK has reported negative net income.
In the past year CHEK has reported a negative cash flow from operations.
In the past 5 years CHEK always reported negative net income.
In the past 5 years CHEK always reported negative operating cash flow.
CHEK Yearly Net Income VS EBIT VS OCF VS FCFCHEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

CHEK's Return On Assets of -100.00% is on the low side compared to the rest of the industry. CHEK is outperformed by 80.00% of its industry peers.
The Return On Equity of CHEK (-105.88%) is worse than 67.57% of its industry peers.
Industry RankSector Rank
ROA -100%
ROE -105.88%
ROIC N/A
ROA(3y)-48.32%
ROA(5y)-72.45%
ROE(3y)-51.73%
ROE(5y)-92.38%
ROIC(3y)N/A
ROIC(5y)N/A
CHEK Yearly ROA, ROE, ROICCHEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CHEK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CHEK Yearly Profit, Operating, Gross MarginsCHEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, CHEK has about the same amount of shares outstanding.
CHEK has more shares outstanding than it did 5 years ago.
CHEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHEK Yearly Shares OutstandingCHEK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
CHEK Yearly Total Debt VS Total AssetsCHEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -11.34, we must say that CHEK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -11.34, CHEK is not doing good in the industry: 81.62% of the companies in the same industry are doing better.
CHEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.34
ROIC/WACCN/A
WACCN/A
CHEK Yearly LT Debt VS Equity VS FCFCHEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 19.78 indicates that CHEK has no problem at all paying its short term obligations.
CHEK's Current ratio of 19.78 is amongst the best of the industry. CHEK outperforms 99.46% of its industry peers.
CHEK has a Quick Ratio of 19.78. This indicates that CHEK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 19.78, CHEK belongs to the top of the industry, outperforming 99.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 19.78
Quick Ratio 19.78
CHEK Yearly Current Assets VS Current LiabilitesCHEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.90% over the past year.
EPS 1Y (TTM)8.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 12.32% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20.31%
EPS Next 2Y12.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHEK Yearly EPS VS EstimatesCHEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CHEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CHEK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHEK Price Earnings VS Forward Price EarningsCHEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHEK Per share dataCHEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 -3

4.3 Compensation for Growth

CHEK's earnings are expected to grow with 12.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.32%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CHEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHECK CAP LTD

NASDAQ:CHEK (8/29/2025, 8:12:29 PM)

After market: 0.681 -0.05 (-7.21%)

0.7339

+0.09 (+14.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)N/A N/A
Inst Owners1.78%
Inst Owner Change27.56%
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap4.29M
Analysts43.33
Price TargetN/A
Short Float %0.62%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.25
EV/EBITDA N/A
EPS(TTM)-3.07
EYN/A
EPS(NY)-2.45
Fwd EYN/A
FCF(TTM)-2.41
FCFYN/A
OCF(TTM)-2.41
OCFYN/A
SpS0
BVpS2.92
TBVpS2.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -100%
ROE -105.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-48.32%
ROA(5y)-72.45%
ROE(3y)-51.73%
ROE(5y)-92.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 19.78
Quick Ratio 19.78
Altman-Z -11.34
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)213.85%
Cap/Depr(5y)207.31%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.47%
EPS Next Y20.31%
EPS Next 2Y12.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.99%
OCF growth 3YN/A
OCF growth 5YN/A